US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
GB0121980D0
(en)
|
2001-09-11 |
2001-10-31 |
Cathnet Science Holding As |
Expandable stent
|
US20030135266A1
(en)
|
2001-12-03 |
2003-07-17 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
US20040186551A1
(en)
|
2003-01-17 |
2004-09-23 |
Xtent, Inc. |
Multiple independent nested stent structures and methods for their preparation and deployment
|
US7294146B2
(en)
|
2001-12-03 |
2007-11-13 |
Xtent, Inc. |
Apparatus and methods for delivery of variable length stents
|
US7351255B2
(en)
|
2001-12-03 |
2008-04-01 |
Xtent, Inc. |
Stent delivery apparatus and method
|
US7137993B2
(en)
|
2001-12-03 |
2006-11-21 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
US7182779B2
(en)
|
2001-12-03 |
2007-02-27 |
Xtent, Inc. |
Apparatus and methods for positioning prostheses for deployment from a catheter
|
US7309350B2
(en)
|
2001-12-03 |
2007-12-18 |
Xtent, Inc. |
Apparatus and methods for deployment of vascular prostheses
|
US8080048B2
(en)
|
2001-12-03 |
2011-12-20 |
Xtent, Inc. |
Stent delivery for bifurcated vessels
|
US7892273B2
(en)
|
2001-12-03 |
2011-02-22 |
Xtent, Inc. |
Custom length stent apparatus
|
US7147656B2
(en)
|
2001-12-03 |
2006-12-12 |
Xtent, Inc. |
Apparatus and methods for delivery of braided prostheses
|
US7084153B2
(en)
*
|
2002-04-12 |
2006-08-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments comprising steroids and a novel anticholinergic
|
US7241308B2
(en)
*
|
2003-06-09 |
2007-07-10 |
Xtent, Inc. |
Stent deployment systems and methods
|
US7553324B2
(en)
*
|
2003-10-14 |
2009-06-30 |
Xtent, Inc. |
Fixed stent delivery devices and methods
|
US7220755B2
(en)
*
|
2003-11-12 |
2007-05-22 |
Biosensors International Group, Ltd. |
42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
|
US7326236B2
(en)
|
2003-12-23 |
2008-02-05 |
Xtent, Inc. |
Devices and methods for controlling and indicating the length of an interventional element
|
ATE418559T1
(de)
*
|
2004-03-01 |
2009-01-15 |
Terumo Corp |
Verfahren zur herstellung von o-alkylierten rapamycinderivaten
|
US7323006B2
(en)
|
2004-03-30 |
2008-01-29 |
Xtent, Inc. |
Rapid exchange interventional devices and methods
|
US8317859B2
(en)
|
2004-06-28 |
2012-11-27 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
US20050288766A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Xtent, Inc. |
Devices and methods for controlling expandable prostheses during deployment
|
US20060034884A1
(en)
*
|
2004-08-10 |
2006-02-16 |
Stenzel Eric B |
Coated medical device having an increased coating surface area
|
US7901451B2
(en)
*
|
2004-09-24 |
2011-03-08 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
US8221824B2
(en)
*
|
2005-02-03 |
2012-07-17 |
Boston Scientific Scimed, Inc. |
Deforming surface of drug eluting coating to alter drug release profile of a medical device
|
US7402168B2
(en)
*
|
2005-04-11 |
2008-07-22 |
Xtent, Inc. |
Custom-length stent delivery system with independently operable expansion elements
|
WO2007011708A2
(en)
|
2005-07-15 |
2007-01-25 |
Micell Technologies, Inc. |
Stent with polymer coating containing amorphous rapamycin
|
KR101406415B1
(ko)
|
2005-07-15 |
2014-06-19 |
미셀 테크놀로지즈, 인코포레이티드 |
제어된 형태의 약물 분말을 함유하는 중합체 코팅
|
US7622477B2
(en)
*
|
2006-02-28 |
2009-11-24 |
Cordis Corporation |
Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same
|
CA2646885A1
(en)
|
2006-03-20 |
2007-09-27 |
Xtent, Inc. |
Apparatus and methods for deployment of linked prosthetic segments
|
AU2007243268B2
(en)
|
2006-04-26 |
2013-06-13 |
Micell Technologies, Inc. |
Coatings containing multiple drugs
|
US20070281117A1
(en)
|
2006-06-02 |
2007-12-06 |
Xtent, Inc. |
Use of plasma in formation of biodegradable stent coating
|
US20080269865A1
(en)
*
|
2006-08-07 |
2008-10-30 |
Xtent, Inc. |
Custom Length Stent Apparatus
|
US20110034503A1
(en)
*
|
2006-08-22 |
2011-02-10 |
Ruey-Shiuan Tsai |
Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders
|
US8088789B2
(en)
*
|
2006-09-13 |
2012-01-03 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
BRPI0716950A2
(pt)
|
2006-09-13 |
2013-10-29 |
Elixir Medical Corp |
Composição farmacêutica, dispositivo para uso intracorpóreo, método para inibir proliferação celular, composto, e, método para preparar um composto
|
US10695327B2
(en)
|
2006-09-13 |
2020-06-30 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US20080097591A1
(en)
*
|
2006-10-20 |
2008-04-24 |
Biosensors International Group |
Drug-delivery endovascular stent and method of use
|
US8067055B2
(en)
*
|
2006-10-20 |
2011-11-29 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method of use
|
US20080103584A1
(en)
*
|
2006-10-25 |
2008-05-01 |
Biosensors International Group |
Temporal Intraluminal Stent, Methods of Making and Using
|
JP5456321B2
(ja)
*
|
2006-11-27 |
2014-03-26 |
テルモ株式会社 |
O−アルキル化ラパマイシン誘導体の製造方法およびo−アルキル化ラパマイシン誘導体
|
US11426494B2
(en)
|
2007-01-08 |
2022-08-30 |
MT Acquisition Holdings LLC |
Stents having biodegradable layers
|
JP5603598B2
(ja)
|
2007-01-08 |
2014-10-08 |
ミセル テクノロジーズ、インコーポレイテッド |
生物分解層を有するステント
|
US20080199510A1
(en)
|
2007-02-20 |
2008-08-21 |
Xtent, Inc. |
Thermo-mechanically controlled implants and methods of use
|
US9888924B2
(en)
|
2007-03-06 |
2018-02-13 |
Covidien Lp |
Wound closure material
|
US8486132B2
(en)
|
2007-03-22 |
2013-07-16 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
US8661630B2
(en)
|
2008-05-21 |
2014-03-04 |
Abbott Cardiovascular Systems Inc. |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
|
AU2008322469B2
(en)
*
|
2007-11-14 |
2014-02-20 |
Biosensors International Group, Ltd. |
Automated coating apparatus and method
|
US9101503B2
(en)
|
2008-03-06 |
2015-08-11 |
J.W. Medical Systems Ltd. |
Apparatus having variable strut length and methods of use
|
US20110098241A1
(en)
*
|
2008-04-14 |
2011-04-28 |
Poniard Pharmaceuticals, Inc. |
Rapamycin analogs as anti-cancer agents
|
BRPI0910969B8
(pt)
|
2008-04-17 |
2021-06-22 |
Micell Technologies Inc |
dispositivo
|
US20100055145A1
(en)
*
|
2008-08-29 |
2010-03-04 |
Biosensors International Group |
Stent coatings for reducing late stent thrombosis
|
US11298252B2
(en)
|
2008-09-25 |
2022-04-12 |
Advanced Bifurcation Systems Inc. |
Stent alignment during treatment of a bifurcation
|
EP2344068B1
(de)
|
2008-09-25 |
2022-10-19 |
Advanced Bifurcation Systems Inc. |
Teilweise gekrimpter stent
|
US8821562B2
(en)
|
2008-09-25 |
2014-09-02 |
Advanced Bifurcation Systems, Inc. |
Partially crimped stent
|
US8769796B2
(en)
|
2008-09-25 |
2014-07-08 |
Advanced Bifurcation Systems, Inc. |
Selective stent crimping
|
CA2743491C
(en)
|
2008-11-11 |
2016-10-11 |
Zelton Dave Sharp |
Inhibition of mammalian target of rapamycin
|
JP2012522589A
(ja)
|
2009-04-01 |
2012-09-27 |
ミシェル テクノロジーズ,インコーポレイテッド |
被覆ステント
|
EP2453834A4
(de)
|
2009-07-16 |
2014-04-16 |
Micell Technologies Inc |
Medizinische wirkstofffreisetzungsvorrichtung
|
US8381774B2
(en)
*
|
2009-09-20 |
2013-02-26 |
Medtronic Vascular, Inc. |
Methods for loading a drug eluting medical device
|
US9283211B1
(en)
|
2009-11-11 |
2016-03-15 |
Rapamycin Holdings, Llc |
Oral rapamycin preparation and use for stomatitis
|
EP2531140B1
(de)
|
2010-02-02 |
2017-11-01 |
Micell Technologies, Inc. |
Stent und stenteinsatzsystem mit verbesserter einsetzbarkeit
|
CA2794080A1
(en)
|
2010-03-24 |
2011-09-29 |
Advanced Bifurcation Systems, Inc. |
System and methods for treating a bifurcation
|
WO2011119883A1
(en)
|
2010-03-24 |
2011-09-29 |
Advanced Bifurcation Systems, Inc. |
Stent alignment during treatment of a bifurcation
|
CA2794064A1
(en)
|
2010-03-24 |
2011-09-29 |
Advanced Bifurcation Systems, Inc. |
Methods and systems for treating a bifurcation with provisional side branch stenting
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
EP2560576B1
(de)
|
2010-04-22 |
2018-07-18 |
Micell Technologies, Inc. |
Stents und andere vorrichtungen mit beschichtung durch eine extrazelluläre matrix
|
WO2012009684A2
(en)
|
2010-07-16 |
2012-01-19 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US9321782B2
(en)
|
2010-08-04 |
2016-04-26 |
Meril Life Sciences Pvt. Ltd. |
Process for preparation of novel 42-O-(heteroalkoxyalkyl) rapamicin compounds with anti-proliferative properties
|
US8632846B2
(en)
*
|
2010-09-17 |
2014-01-21 |
Medtronic Vascular, Inc. |
Apparatus and methods for loading a drug eluting medical device
|
CA2821905C
(en)
|
2010-12-16 |
2018-07-10 |
Sumitomo Seika Chemicals Co., Ltd. |
Method for producing pseudopolyrotaxane aqueous dispersion
|
ES2552038T3
(es)
|
2010-12-16 |
2015-11-25 |
Sumitomo Seika Chemicals Co., Ltd. |
Método para la producción de un pseudopolirrotaxano
|
WO2012081429A1
(ja)
|
2010-12-16 |
2012-06-21 |
住友精化株式会社 |
擬ポリロタキサンの製造方法
|
WO2012081432A1
(ja)
*
|
2010-12-16 |
2012-06-21 |
住友精化株式会社 |
精製ポリロタキサンの製造方法
|
EP3449879B1
(de)
|
2011-02-08 |
2020-09-23 |
Advanced Bifurcation Systems Inc. |
System zur behandlung einer bifurkation mit einem vollständig gecrimpten stent
|
WO2012109382A2
(en)
|
2011-02-08 |
2012-08-16 |
Advanced Bifurcation Systems, Inc. |
Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
|
WO2012124217A1
(ja)
*
|
2011-03-14 |
2012-09-20 |
住友精化株式会社 |
粉末状親水性修飾ポリロタキサンの製造方法
|
US9266972B2
(en)
*
|
2011-03-14 |
2016-02-23 |
Sumitomo Seika Chemicals Co., Ltd. |
Polyrotaxane composition
|
CN103415537B
(zh)
*
|
2011-03-14 |
2016-06-22 |
住友精化株式会社 |
亲水性改性聚轮烷的制造方法
|
US10188772B2
(en)
|
2011-10-18 |
2019-01-29 |
Micell Technologies, Inc. |
Drug delivery medical device
|
EP2589383A1
(de)
|
2011-11-06 |
2013-05-08 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin |
FKBP-subtypspezifisches Rapamycin-Analogon zur Verwendung bei der Behandlung von Erkrankungen
|
KR20150010716A
(ko)
|
2012-03-23 |
2015-01-28 |
더 유니버시티 오브 퀸스랜드 |
면역조절제 및 이의 용도
|
US20150094463A1
(en)
*
|
2012-03-30 |
2015-04-02 |
Ube Industries, Ltd. |
Hydroxyalkylated polyrotaxane production method
|
US9364273B2
(en)
|
2012-08-15 |
2016-06-14 |
DePuy Synthes Products, Inc. |
Drug eluting surgical screw
|
CN110123759A
(zh)
|
2012-12-03 |
2019-08-16 |
曼丽国际有限公司 |
Umirolimus及其衍生物用于治疗癌症的用途
|
SG11201505719TA
(en)
*
|
2013-01-22 |
2015-09-29 |
Biosensors Int Group Ltd |
Low temperature synthesis of rapamycin derivatives
|
EP2967803B1
(de)
*
|
2013-03-12 |
2023-12-27 |
Micell Technologies, Inc. |
Bioabsorbierbare biomedizinische implantate
|
WO2014160328A1
(en)
|
2013-03-13 |
2014-10-02 |
The Board Of Regents Of The University Of Texas System |
Mtor inhibitors for prevention of intestinal polyp growth
|
CN108864149B
(zh)
|
2013-03-15 |
2022-04-05 |
生物传感器国际集团有限公司 |
雷帕霉素衍生物的纯化
|
KR102079613B1
(ko)
|
2013-05-15 |
2020-02-20 |
미셀 테크놀로지즈, 인코포레이티드 |
생흡수성 생체의학적 임플란트
|
US20150073998A1
(en)
|
2013-09-09 |
2015-03-12 |
Apple Inc. |
Use of a Biometric Image in Online Commerce
|
MX2016006316A
(es)
|
2013-11-13 |
2016-07-26 |
Novartis Ag |
Inhibidores de mtor para potenciar la respuesta inmunitaria.
|
US10640569B2
(en)
|
2013-12-19 |
2020-05-05 |
Novartis Ag |
Human mesothelin chimeric antigen receptors and uses thereof
|
WO2015090229A1
(en)
|
2013-12-20 |
2015-06-25 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
US9700544B2
(en)
|
2013-12-31 |
2017-07-11 |
Neal K Vail |
Oral rapamycin nanoparticle preparations
|
AU2014373683B2
(en)
|
2013-12-31 |
2020-05-07 |
Rapamycin Holdings, Llc |
Oral rapamycin nanoparticle preparations and use
|
EP3593812A3
(de)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Behandlung von krebs mithilfe eines chimären antigenrezeptors
|
EP3119425B1
(de)
|
2014-03-15 |
2020-09-23 |
Novartis AG |
Regulierbarer chimärer antigenrezeptor
|
RU2718542C2
(ru)
|
2014-04-07 |
2020-04-08 |
Новартис Аг |
Лечение злокачественной опухоли с использованием химерного рецептора антигена против cd19
|
JP6300926B2
(ja)
*
|
2014-07-08 |
2018-03-28 |
国立大学法人大阪大学 |
自己修復性を有する高分子材料及びその製造方法
|
JP2017528433A
(ja)
|
2014-07-21 |
2017-09-28 |
ノバルティス アーゲー |
低い免疫増強用量のmTOR阻害剤とCARの組み合わせ
|
US11542488B2
(en)
|
2014-07-21 |
2023-01-03 |
Novartis Ag |
Sortase synthesized chimeric antigen receptors
|
MX2017001008A
(es)
|
2014-07-21 |
2017-08-02 |
Novartis Ag |
Tratamiento de cancer utilizando un receptor quimerico de antigeno cd33.
|
EP3174546B1
(de)
|
2014-07-31 |
2019-10-30 |
Novartis AG |
Teilmengenoptimierte chimäre antigenrezeptorhaltige t-zellen
|
WO2016025880A1
(en)
|
2014-08-14 |
2016-02-18 |
Novartis Ag |
Treatment of cancer using gfr alpha-4 chimeric antigen receptor
|
MY189028A
(en)
|
2014-08-19 |
2022-01-20 |
Novartis Ag |
Anti-cd123 chimeric antigen receptor (car) for use in cancer treatment
|
WO2016040806A1
(en)
|
2014-09-11 |
2016-03-17 |
The Regents Of The University Of California |
mTORC1 INHIBITORS
|
BR112017005390A2
(pt)
|
2014-09-17 |
2017-12-12 |
Novartis Ag |
células citotóxicas alvo com receptores quiméricos para imunoterapia adotiva
|
KR20170068504A
(ko)
|
2014-10-08 |
2017-06-19 |
노파르티스 아게 |
키메라 항원 수용체 요법에 대한 치료 반응성을 예측하는 바이오마커 및 그의 용도
|
WO2016090034A2
(en)
|
2014-12-03 |
2016-06-09 |
Novartis Ag |
Methods for b cell preconditioning in car therapy
|
US11161907B2
(en)
|
2015-02-02 |
2021-11-02 |
Novartis Ag |
Car-expressing cells against multiple tumor antigens and uses thereof
|
US20180140602A1
(en)
|
2015-04-07 |
2018-05-24 |
Novartis Ag |
Combination of chimeric antigen receptor therapy and amino pyrimidine derivatives
|
EP4234685A3
(de)
|
2015-04-17 |
2023-09-06 |
Novartis AG |
Verfahren zur verbesserung der wirksamkeit und expansion chimärer antigen-rezeptor-exprimierender zellen
|
WO2016172583A1
(en)
|
2015-04-23 |
2016-10-27 |
Novartis Ag |
Treatment of cancer using chimeric antigen receptor and protein kinase a blocker
|
CN107847491A
(zh)
|
2015-05-20 |
2018-03-27 |
诺华公司 |
依维莫司(everolimus)与达托里昔布(dactolisib)的医药组合
|
CA2992551A1
(en)
|
2015-07-21 |
2017-01-26 |
Novartis Ag |
Methods for improving the efficacy and expansion of immune cells
|
JP2018537447A
(ja)
|
2015-11-11 |
2018-12-20 |
ノバルティス アーゲー |
ミオスタチンアンタゴニストの使用、それを含有する組合せ物およびその使用
|
CA3016287A1
(en)
|
2016-03-04 |
2017-09-08 |
Novartis Ag |
Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore
|
CA3039646A1
(en)
|
2016-10-07 |
2018-04-12 |
Novartis Ag |
Chimeric antigen receptors for the treatment of cancer
|
TW201825090A
(zh)
|
2016-11-23 |
2018-07-16 |
瑞士商諾華公司 |
增強免疫反應之方法
|
US20200055948A1
(en)
|
2017-04-28 |
2020-02-20 |
Novartis Ag |
Cells expressing a bcma-targeting chimeric antigen receptor, and combination therapy with a gamma secretase inhibitor
|
US20210154372A1
(en)
|
2017-05-15 |
2021-05-27 |
C.R. Bard, Inc. |
Medical device with drug-eluting coating and intermediate layer
|
US10596165B2
(en)
|
2018-02-12 |
2020-03-24 |
resTORbio, Inc. |
Combination therapies
|
US20210047405A1
(en)
|
2018-04-27 |
2021-02-18 |
Novartis Ag |
Car t cell therapies with enhanced efficacy
|
CR20200578A
(es)
|
2018-05-01 |
2021-02-22 |
Revolution Medicines Inc |
Análogos de rapamicina a c40, c28 y c32 como inhibidores de mtor
|
WO2019213282A1
(en)
|
2018-05-01 |
2019-11-07 |
Novartis Ag |
Biomarkers for evaluating car-t cells to predict clinical outcome
|
JP7381492B2
(ja)
|
2018-05-01 |
2023-11-15 |
レヴォリューション・メディスンズ,インコーポレイテッド |
Mtor阻害剤としてのc26-連結ラパマイシン類似体
|
MX2020013630A
(es)
|
2018-06-15 |
2021-04-28 |
Anakuria Therapeutics Inc |
Analogos de rapamicina y usos de los mismos.
|
JP7262581B2
(ja)
|
2018-11-14 |
2023-04-21 |
ルトニックス,インコーポレーテッド |
改質されたデバイス表面に薬物溶出コーティングを有する医療用デバイス
|
WO2020209828A1
(en)
|
2019-04-08 |
2020-10-15 |
Bard Peripheral Vascular, Inc. |
Medical device with drug-eluting coating on modified device surface
|
US11517457B2
(en)
*
|
2019-07-03 |
2022-12-06 |
Abbott Cardiovascular Systems Inc. |
Intravascular stent
|
KR20220128345A
(ko)
*
|
2019-12-05 |
2022-09-20 |
아나쿠리아 테라퓨틱스, 인코포레이티드 |
라파마이신 유사체 및 이의 용도
|